{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:01:28Z","timestamp":1758042088416,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T00:00:00Z","timestamp":1471824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ajo.2016.08.022","type":"journal-article","created":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T21:09:08Z","timestamp":1472159348000},"page":"35-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Randomized, Controlled, Phase 3 Trials of Carteolol\/Latanoprost Fixed Combination in Primary Open-Angle Glaucoma or Ocular Hypertension"],"prefix":"10.1016","volume":"171","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6683-0144","authenticated-orcid":false,"given":"Tetsuya","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1642-9982","authenticated-orcid":false,"given":"Toru","family":"Ikegami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0084-2585","authenticated-orcid":false,"given":"Yuji","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0490-8759","authenticated-orcid":false,"given":"Satoru","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajo.2016.08.022_bib1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ophtha.2015.10.055","article-title":"Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern\u00ae Guidelines","volume":"123","author":"Prum","year":"2016","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2016.08.022_bib2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2016.08.022_bib3","first-page":"3","article-title":"The Japan Glaucoma Society guidelines for glaucoma (3rd edition)","volume":"116","year":"2012","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"2","key":"10.1016\/j.ajo.2016.08.022_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/jop.2014.0067","article-title":"Pharmacotherapy of glaucoma","volume":"31","author":"Schmidl","year":"2015","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.ajo.2016.08.022_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1586\/erp.10.83","article-title":"Role of fixed combinations in the management of open-angle glaucoma","volume":"11","author":"Hommer","year":"2011","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"10","key":"10.1016\/j.ajo.2016.08.022_bib6","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1185\/03007990903260129","article-title":"Glaucoma medication persistence with a fixed combination versus multiple bottles","volume":"25","author":"Higginbotham","year":"2009","journal-title":"Curr Med Res Opin"},{"issue":"12","key":"10.1016\/j.ajo.2016.08.022_bib7","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1517\/14656566.2014.936850","article-title":"Fixed-combination intraocular pressure-lowering therapy for glaucoma and ocular hypertension: advantages in clinical practice","volume":"15","author":"Holl\u00f3","year":"2014","journal-title":"Expert Opin Pharmacother"},{"issue":"11","key":"10.1016\/j.ajo.2016.08.022_bib8","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1076\/ceyr.16.11.1102.5101","article-title":"Effect of topical beta-blockers on tissue blood flow in the human optic nerve head","volume":"16","author":"Tamaki","year":"1997","journal-title":"Curr Eye Res"},{"issue":"3","key":"10.1016\/j.ajo.2016.08.022_bib9","first-page":"95","article-title":"Multicenter double-blind comparison of carteolol and timolol in primary open-angle glaucoma and ocular hypertension","volume":"10","author":"Kitazawa","year":"1993","journal-title":"Adv Ther"},{"issue":"4","key":"10.1016\/j.ajo.2016.08.022_bib10","first-page":"1259","article-title":"The effect of ophthalmic \u03b2-adrenergic-blocking agents on patients with bronchial asthma\u2013The comparison of carteolol and timolol","volume":"16","author":"Sano","year":"1984","journal-title":"New Horizon for Medicine (Gendai Iryo)"},{"issue":"2","key":"10.1016\/j.ajo.2016.08.022_bib11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0002-9394(88)90178-X","article-title":"A double-masked comparison of carteolol and timolol in ocular hypertension","volume":"105","author":"Scoville","year":"1988","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2016.08.022_bib12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00061198-199608000-00007","article-title":"The effects of the \u03b2-adrenergic-blocking agents, timolol and carteolol, on plasma lipids and lipoproteins in Japanese glaucoma patients","volume":"5","author":"Yamamoto","year":"1996","journal-title":"J Glaucoma"},{"issue":"8","key":"10.1016\/j.ajo.2016.08.022_bib13","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/bjo.85.8.921","article-title":"Ocular hypotensive efficacy and safety of once daily carteolol alginate","volume":"85","author":"Demailly","year":"2001","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2016.08.022_bib14","first-page":"131","article-title":"Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study","volume":"26","author":"Trinquand","year":"2003","journal-title":"J Fr Ophtalmol"},{"issue":"6","key":"10.1016\/j.ajo.2016.08.022_bib15","first-page":"463","article-title":"Ocular hypotensive effect of 1% carteolol long-acting eye drops \u2013 a double-masked, randomized phase III study in ocular hypertension or primary open-angle glaucoma patients comparing long-acting carteolol eye drops vs. current product","volume":"111","author":"Yamamoto","year":"2007","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"11","key":"10.1016\/j.ajo.2016.08.022_bib16","first-page":"976","article-title":"Long-acting carteolol hydrochloride 2% ophthalmic solution phase IV study \u2013 investigation of the effectiveness, safety and plasma concentration","volume":"114","author":"Kawase","year":"2010","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"9975","key":"10.1016\/j.ajo.2016.08.022_bib17","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(14)62111-5","article-title":"Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial","volume":"385","author":"Garway-Heath","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ajo.2016.08.022_bib18","first-page":"14","article-title":"The ocular hypotensive effect of long-acting carteolol added to latanoprost","volume":"3","author":"Inoue","year":"2010","journal-title":"Folia Japonica de Ophthalmologica Clinica (Ganka Rinsho Kiyo)"},{"issue":"9","key":"10.1016\/j.ajo.2016.08.022_bib19","first-page":"1291","article-title":"Effect of long-acting carteolol in patients with primary open-angle glaucoma","volume":"25","author":"Inoue","year":"2008","journal-title":"J Eye (Atarashii Ganka)"},{"issue":"7","key":"10.1016\/j.ajo.2016.08.022_bib20","first-page":"1017","article-title":"Optic nerve head blood flow changes induced by long-acting beta-blocker addition to latanoprost in primary open-angle glaucoma","volume":"28","author":"Shibata","year":"2011","journal-title":"J Eye (Atarashii Ganka)"},{"issue":"2","key":"10.1016\/j.ajo.2016.08.022_bib21","first-page":"91","article-title":"Comparison of ocular hypotensive and adverse effect of 2 types of long-acting \u03b2 blocker when added to patients with latanoprost monotherapy","volume":"6","author":"Arakaki","year":"2013","journal-title":"Folia Jpn de Ophthalmol Clin (Ganka Rinsho Kiyo)"},{"issue":"3","key":"10.1016\/j.ajo.2016.08.022_bib22","first-page":"195","article-title":"Decrease in intraocular pressure after switching to latanoprost from a \u03b2-adrenergic receptor blocker medication in patients with open-angle glaucoma","volume":"57","author":"Yukawa","year":"2006","journal-title":"Folia Ophthalmologica Japonica (Nihon Ganka Kiyo)"},{"issue":"12","key":"10.1016\/j.ajo.2016.08.022_bib23","first-page":"1159","article-title":"Effect of latanoprost on intraocular pressure in patients with open-angle glaucoma","volume":"101","author":"Ono","year":"2007","journal-title":"Jpn Rev Clin Ophthalmol (Ganka Rinsho Iho)"},{"issue":"2","key":"10.1016\/j.ajo.2016.08.022_bib24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1089\/jop.2007.0016","article-title":"Effects of switching from topical \u03b2-blockers to latanoprost on intraocular pressure in patients with normal-tension glaucoma","volume":"24","author":"Ikeda","year":"2008","journal-title":"J Ocul Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.ajo.2016.08.022_bib25","first-page":"1641","article-title":"The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study","volume":"111","author":"Iwase","year":"2004","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2016.08.022_bib26","first-page":"807","article-title":"Phase III double-blind study of latanoprost\/timolol combination (KP2035) in patients with primary open-angle glaucoma or ocular hypertension","volume":"63","author":"Kitazawa","year":"2009","journal-title":"Jpn J Clin Ophthalmol (Rinsho Ganka)"},{"issue":"3","key":"10.1016\/j.ajo.2016.08.022_bib27","first-page":"425","article-title":"Comparison of ocular hypotensive effect and safety between the unfixed combination of long-acting carteolol 2% hydrochloride added to latanoprost 0.005% and the fixed combination ophthalmic solution of latanoprost 0.005%\/timolol maleate 0.5%","volume":"32","author":"Uchida","year":"2015","journal-title":"J Eye (Atarashii Ganka)"},{"issue":"11","key":"10.1016\/j.ajo.2016.08.022_bib28","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/j.ophtha.2010.03.024","article-title":"The intraocular pressure-lowering effect of prostaglandin analogs combined with topical \u03b2-blocker therapy: a systematic review and meta-analysis","volume":"117","author":"Webers","year":"2010","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2016.08.022_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bjo.2003.018234","article-title":"A 12\u00a0week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension","volume":"88","author":"Diestelhorst","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2016.08.022_bib30","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/01.ijg.0000176935.08392.14","volume":"14","author":"Hughes","year":"2005","journal-title":"J Glaucoma"},{"issue":"10","key":"10.1016\/j.ajo.2016.08.022_bib31","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/S0161-6420(98)91045-4","article-title":"The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study Group","volume":"105","author":"Strohmaier","year":"1998","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2016.08.022_bib32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/112067210801800110","article-title":"Comparison of intraocular pressure lowering effect of once daily morning vs evening dosing of latanoprost\/timolol maleate combination","volume":"18","author":"Takmaz","year":"2008","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2016.08.022_bib33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1755-3768.2007.01145.x","article-title":"Intraocular pressure control over 24 hours using travoprost and timolol fixed combination administered in the morning or evening in primary open-angle and exfoliative glaucoma","volume":"87","author":"Konstas","year":"2009","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2016.08.022_bib34","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/bjo.2007.135111","article-title":"Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials","volume":"93","author":"Honrubia","year":"2009","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2016.08.022_bib35","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/IJG.0b013e31825af67d","article-title":"Preservative exposure and surgical outcomes in glaucoma patients: the PESO study","volume":"22","author":"Boimer","year":"2013","journal-title":"J Glaucoma"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939416304068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939416304068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:32:24Z","timestamp":1757597544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939416304068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":35,"alternative-id":["S0002939416304068"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2016.08.022","relation":{},"ISSN":["0002-9394"],"issn-type":[{"type":"print","value":"0002-9394"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized, Controlled, Phase 3 Trials of Carteolol\/Latanoprost Fixed Combination in Primary Open-Angle Glaucoma or Ocular Hypertension","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2016.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}